About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank


« USPTO Requests Comments on Enhancement of Patent Quality | Main | Biotech/Pharma Docket »

December 14, 2009



At an en banc oral argument, I find it very strange that Michel would focus on such minutia as whether Eli Lilly had preserved their right to object to a jury instruction. There were far more important matters that needed to be addressed. And as you correctly pointed out, everyone tip toed around the most importantly, namely what's required to satisfy "written description," be it separate and distinct, or otherwise


Be "written description" not separate and distinct, the plain language of the statute tells you the level to be satisfied.

It is only when "written description" is made separate and distinct does the plain language of the statute not tell you the level.

I have found it rather surprising that the court as well as the pundits have not picked up on the discussion of the second question.

The comments to this entry are closed.

May 2024

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31